Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders. (Q42439138)

31 October 2017

title

Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders. (English)

1 reference

31 October 2017

1 reference

Alexandra Kautzky-Willer

3

1 reference

31 October 2017

Andrea Tura

1

1 reference

31 October 2017

Giovanni Pacini

2

1 reference

31 October 2017

Bernhard Ludvik

4

1 reference

31 October 2017

Rudolf Prager

5

1 reference

31 October 2017

Karl Thomaseth

6

1 reference

31 October 2017

publication date

1 April 2003

1 reference

American Journal of Physiology - Endocrinology and Metabolism

31 October 2017

published in

1 reference

31 October 2017

volume

285

1 reference

31 October 2017

issue

1

1 reference

31 October 2017

page(s)

E155-62

1 reference

Statistical methods for assessing agreement between two methods of clinical measurement

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

Beta-cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

Mathematical models of insulin secretion in physiological and clinical investigations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

Newly synthesized proinsulin/insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

Integrated mathematical model to assess beta-cell activity during the oral glucose test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

Amylin release during oral glucose tolerance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00104.2002

10.1152/AJPENDO.00104.2002

21 January 2018

Identifiers

DOI

1 reference

31 October 2017

1 reference